A local paracrine and endocrine network involving TGFβ, Cox-2, ROS, and estrogen receptor β influences reactive stromal cell regulation of prostate cancer cell motility.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Molecular Endocrinology

• Publication date

  2012-05-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/me.2011-1371PMID 22593181PMCID PMC3355541
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An ADIOL-ER b-CtBP Transrepression Pathway Negatively Regulates Microglia-Mediated Inflammation

  2011cited by this paper
• Homeodomain protein DLX4 counteracts key transcriptional control mechanisms of the TGF-β cytostatic program and blocks the anti-proliferative effect of TGF-β

  2011cited by this paper
• Steroid hormone receptors in cancer development: a target for cancer therapeutics.

  2011cited by this paper
• Tgf-β1 expression as a biomarker of poor prognosis in prostate cancer

  2011cited by this paper
• Altered TGF-β signaling in a subpopulation of human stromal cells promotes prostatic carcinogenesis.

  2011cited by this paper
• The different roles of ER subtypes in cancer biology and therapy

  2011cited by this paper
• ROS signaling by NOX4 drives fibroblast-to-myofibroblast differentiation in the diseased prostatic stroma.

  2011cited by this paper
• Cancer Associated Fibroblasts Exploit Reactive Oxygen Species Through a Proinflammatory Signature Leading to Epithelial Mesenchymal Transition and Stemness

  2011cited by this paper
• Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer.

  2010cited by this paper
• Estrogen receptor beta and the progression of prostate cancer: role of 5alpha-androstane-3beta,17beta-diol.

  2010cited by this paper
• ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading.

  2010cited by this paper
• The Dual, Opposing Roles of Estrogen in the Prostate

  2009cited by this paper
• Oxidative stress in prostate cancer.

  2009cited by this paper
• Low COX2 in tumor and upregulation in stroma mark laryngeal squamous cell carcinoma progression

  2009cited by this paper
• Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype.

  2008cited by this paper
• TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study

  2007cited by this paper
• Association between polymorphisms in HSD3B1 and UGT2B17 and prostate cancer risk.

  2007cited by this paper
• Cyclooxygenase-2-dependent neuronal death proceeds via superoxide anion generation.

  2006cited by this paper
• An Inverse Relation Between COX-2 and E-cadherin Expression Correlates With Aggressive Histologic Features in Prostate Cancer

  2006cited by this paper
• Alterations in components of the TGF-beta superfamily signaling pathways in human cancer.

  2006cited by this paper
• Development of Nonsteroidal Anti-Inflammatory Drug Analogs and Steroid Carboxylates Selective for Human Aldo-Keto Reductase Isoforms: Potential Antineoplastic Agents That Work Independently of Cyclooxygenase Isozymes

  2005cited by this paper
• TGF-beta inhibitors for the treatment of cancer.

  2005cited by this paper
• Prostate carcinogenesis and inflammation: emerging insights.

  2005cited by this paper
• Reactivity of zinc finger cysteines: Chemical modifications within labile zinc fingers in estrogen receptor

  2005cited by this paper
• A system for studying epithelial-stromal interactions reveals distinct inductive abilities of stromal cells from benign prostatic hyperplasia and prostate cancer.

  2005cited by this paper
• The androgen derivative 5alpha-androstane-3beta,17beta-diol inhibits prostate cancer cell migration through activation of the estrogen receptor beta subtype.

  2005cited by this paper
• TGF-β inhibitors for the treatment of cancer

  2005cited by this paper
• Profiling molecular targets of TGF-beta1 in prostate fibroblast-to-myofibroblast transdifferentiation.

  2005cited by this paper
• Local aromatase expression in human prostate is altered in malignancy.

  2004cited by this paper
• Expression of ERα and ERβ in prostate cancer

  2003cited by this paper
• Expression of ERalpha and ERbeta in prostate cancer.

  2003cited by this paper
• Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer.

  2003cited by this paper
• Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.

  2002cited by this paper
• Joint effect of HSD3B1 and HSD3B2 genes is associated with hereditary and sporadic prostate cancer susceptibility.

  2002cited by this paper
• Inflammation and cancer

  2002cited by this paper
• Role of stroma in carcinogenesis of the prostate.

  2002cited by this paper
• TGF-beta signaling in cancer--a double-edged sword.

  2001cited by this paper
• TGF-β signaling in cancer – a double-edged sword

  2001cited by this paper
• Host cyclooxygenase-2 modulates carcinoma growth.

  2000cited by this paper
• Preferential oxidation of zinc finger 2 in estrogen receptor DNA-binding domain prevents dimerization and, hence, DNA binding.

  2000cited by this paper
• Arachidonic Acid Oxygenation by COX-1 and COX-2

  1999cited by this paper
• Molecular expression of 17 beta hydroxysteroid dehydrogenase types in relation to their activity in intact human prostate cancer cells.

  1997cited by this paper
• TGF beta in prostate cancer: a growth inhibitor that can enhance tumorigenicity.

  1997cited by this paper
• Expression of different 17beta-hydroxysteroid dehydrogenase types and their activities in human prostate cancer cells.

  1997cited by this paper
• TGFβ in prostate cancer: A growth inhibitor that can enhance tumorigenicity

  1997cited by this paper
• Cell migration: interactions among integrins, IGFs and IGFBPs.

  1995cited by this paper
• Role of mesenchymal‐epithelial interactions in normal and abnormal development of the mammary gland and prostate

  1994cited by this paper
• The distribution of secondary growths in cancer of the breast. 1889.

  1989cited by this paper
• Differential effects of transforming growth factor beta on human prostate cancer cells in vitro.

  1989cited by this paper
• Differential effects of transforming growth factor β on human prostate cancer cells in vitro

  1989cited by this paper
• Printed in U.S.A. Copyright © 1997 by The Endocrine Society Expression of Different 17�-Hydroxysteroid Dehydrogenase Types and Their Activities in Human Prostate Cancer Cells*

  year unknowncited by this paper

• Cancer-Associated Fibroblasts in Prostate Cancer: Unraveling Mechanisms and Therapeutic Implications

  2026cites this paper
• Propagation of a rapid cell-to-cell H2O2 signal over long distances in a monolayer of cardiomyocyte cells

  2024cites this paper
• Exosomal ITGB6 from dormant lung adenocarcinoma cells activates cancer-associated fibroblasts by KLF10 positive feedback loop and the TGF-β pathway

  2023cites this paper
• Nuclear Estrogen Receptors in Prostate Cancer: From Genes to Function

  2023cites this paper
• Cancer-Associated Fibroblast Heterogeneity, Activation and Function: Implications for Prostate Cancer

  2022cites this paper
• Estrogen receptor-β signaling induces cisplatin resistance in bladder cancer.

  2020cites this paper
• Heart failure as interstitial cancer: emergence of a malignant fibroblast phenotype

  2019cites this paper
• Estrogen receptor β plays a protective role in zearalenone-induced oxidative stress in normal prostate epithelial cells.

  2019cites this paper
• Elucidating the role of TGFβ signalling in drug resistant Hh driven cancers

  2018cites this paper
• Torulene and torularhodin, protects human prostate stromal cells from hydrogen peroxide-induced oxidative stress damage through the regulation of Bcl-2/Bax mediated apoptosis

  2017cites this paper
• Inhibition of Wound TGF Beta-1 by Celecoxib: A Possible Therapeutic Route for Scar Free Wound

  2017cites this paper
• Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity

  2017cites this paper
• Hypoxia and Inflammation in Prostate Cancer Progression. Cross-talk with Androgen and Estrogen Receptors and Cancer Stem Cells.

  2017cites this paper
• Investigating the role of the secreted tumour suppressor Dickkopf-3 in stromal-epithelial interactions in prostate cancer

  2017cites this paper
• Estrogen receptor beta modulates prostate carcinogenesis

  2017cites this paper
• MicroRNA-382-5p aggravates breast cancer progression by regulating the RERG/Ras/ERK signaling axis

  2016cites this paper
• WOMEN IN CANCER THEMATIC REVIEW: New roles for nuclear receptors in prostate cancer.

  2016cites this paper
• Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-Reductase Inhibition in Prostate Epithelial Cells*

  2016cites this paper
• The role of TGF-β/Smad signaling in dopamine agonist-resistant prolactinomas.

  2015cites this paper
• Caveolae and signalling in cancer

  2015cites this paper
• UpregulationofAndrogen-ResponsiveGenesand TransformingGrowthFactor-b1CascadeGenesinaRat Modelof Non-Bacterial Prostatic Inflammation

  2014cites this paper
• TGF-beta in CAF-mediated tumor growth and metastasis.

  2014cites this paper
• REVIEW FOR THE SHEIKH HAMDAN BIN RASHID AL MAKTOUM AWARD FOR MEDICAL SCIENCES Antiproliferative and pro-apoptotic actions of oestrogen receptor β in prostate cancer

  2014cites this paper
• Estrogen receptor α in cancer-associated fibroblasts suppresses prostate cancer invasion via modulation of thrombospondin 2 and matrix metalloproteinase 3.

  2014cites this paper
• Upregulation of androgen‐responsive genes and transforming growth factor‐β1 cascade genes in a rat model of non‐bacterial prostatic inflammation

  2014cites this paper
• Estrogen receptor beta in prostate cancer: friend or foe?

  2014cites this paper
• Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples.

  2013cites this paper
• Transcription Factor Networks in Invasion-Promoting Breast Carcinoma-Associated Fibroblasts

  2013cites this paper
• Insight into the mechanisms of action of estrogen receptor β in the breast, prostate, colon, and CNS.

  2013cites this paper
• Local endocrine, paracrine and redox signaling networks impact estrogen and androgen crosstalk in the prostate cancer microenvironment.

  2013cites this paper
• Loss of caveolin‐1 in prostate cancer stroma correlates with reduced relapse‐free survival and is functionally relevant to tumour progression

  2013cites this paper